Sino Biological introduces target protein collections

By Setform

As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development, access to well-characterised target proteins is essential for evaluating AI-designed molecules. Sino Biological, a global biotechnology company specialising in recombinant proteins, antibodies and CRO services, has introduced two dedicated target protein collections for AI-driven discovery: AI-trusted proteins and AI-qualified proteins.

Together, these collections offer researchers access to target proteins with demonstrated use in AI research, experimentally characterised binding activity, and specialised formats to support diverse AI-driven validation.

Two collections, two ways to support AI validation

AI-trusted proteins — Proven in AI research

AI-Trusted Proteins have been used in AI-focused company validation projects, with some proteins featured in published research. This collection currently covers 600+ targets and 960+ individual proteins, with available characterisation data for each protein potentially including SPR, BLI, ELISA, cell-based activity assays, SEC-HPLC, and SEC-MALS analyses.

AI-qualified proteins — Characterised for AI validation

AI-Qualified Proteins feature experimentally characterised target binding activity, including SPR/BLI validation data, as well as specialised formats such as biotinylated proteins for AI-driven research. With 680+ targets and 1,700+ individual proteins, this collection provides researchers with a broad selection of characterised target proteins for evaluating AI-designed molecules.

The 4S System: Building confidence in target protein resources

Supporting these collections is Sino Biological’s 4S System — Scale, Scope, Speed, and Supply, designed to provide the resource breadth, production capabilities, and supply reliability required by AI-driven discovery.

  • Scale: More than 11,000 recombinant target proteins, including over 1,200 biotinylated proteins.
  • Scope: Broad coverage of membrane, extracellular, and intracellular proteins, as well as mutants and diverse protein formats.
  • Speed: Rapid, scalable production, efficient order processing, and local inventory and delivery capabilities.
  • Supply: Lot-to-lot consistency, multi-lot availability, and reliable long-term supply.

Together, the 4S System helps researchers access a broad range of target proteins while supporting consistent experimental needs and ongoing AI research programs.

Sino Biological has also developed a therapeutic target directory covering 12 therapeutic areas and more than 100 diseases, enabling researchers to explore relevant targets by therapeutic area or disease.

4RISE: Connecting target resources with end-to-end AI validation

Target proteins are a critical part of experimental validation. As a key resource within Sino Biological’s 4RISE AI Lab Validation Solution, the AI-focused target protein library works alongside high-throughput protein expression, binding and affinity characterisation, developability assessment, and functional validation.

Built around four strengths — Rapid, In-Depth, Seamless, and Empirical — 4RISE provides integrated wet-lab support to help researchers advance AI-designed molecules from computational predictions to experimental evidence.

“AI-driven discovery depends on reliable experimental resources to evaluate designed molecules and guide subsequent research decisions,” said Dr Rob Burgess, chief business officer at Sino Biological US. “By combining AI-Trusted and AI-Qualified target proteins with our 4S System, we aim to provide researchers with well-characterised target resources, broad coverage, and dependable supply to support AI-driven protein and antibody discovery.”

Share This Article
Leave a Comment

Subscribe to our Newsletter

© 2026 Setform Limited.